Metabolism of minor isoforms of prion proteins Cytosolic prion protein and transmembrane prion protein

被引:4
|
作者
Song, Zhiqi [1 ]
Zhao, Deming [1 ]
Yang, Lifeng [1 ]
机构
[1] China Agr Univ, State Key Lab Agrobiotechnol, Natl Anim Transmissible Spongiform Encephalopathy, Coll Vet Med, Beijing 100193, Peoples R China
基金
中国国家自然科学基金;
关键词
neural regeneration; neurodegeneration; prion protein; cytosolic form of prion protein; transmembrane form of priori protein; metabolism; protein degeneration; ubiquitination; molecular chaperone; molecular mechanism; neuroregeneration; ENDOPLASMIC-RETICULUM MEMBRANE; SIGNAL SEQUENCE RECOGNITION; PRPSC-LIKE CONFORMATION; NEURODEGENERATIVE DISEASES; SPONGIFORM ENCEPHALOPATHY; PROTEASOME DEGRADATION; TRANSLOCATION CHANNEL; SECRETORY PATHWAY; MAMMALIAN PRIONS; QUALITY-CONTROL;
D O I
10.3969/j.issn.1673-5374.2013.30.009
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Transmissible spongiform encephalopathy or prion disease is triggered by the conversion from cellular prion protein to pathogenic prion protein. Growing evidence has concentrated on prion protein configuration changes and their correlation with prion disease transmissibility and pathogenicity. In vivo and in vitro studies have shown that several cytosolic forms of priori protein with specific topological structure can destroy intracellular stability and contribute to priori protein pathogenicity. In this study, the latest molecular chaperone system associated with endoplasmic reticulum-associated protein degradation, the endoplasmic reticulum resident protein quality-control system and the ubiquitination proteasome system, is outlined. The molecular chaperone system directly correlates with the prion protein degradation pathway. Understanding the molecular mechanisms will help provide a fascinating avenue for further investigations on prion disease treatment and prion protein-induced neurodegenerative diseases.
引用
收藏
页码:2868 / 2878
页数:11
相关论文
共 50 条
  • [41] Evidence for oxidative damage to prion protein in prion diseases
    YANG Chiming (Chi Ming Yang)Institute for Life Science and Health at UCSD
    Chinese Science Bulletin, 2000, (17) : 1546 - 1554
  • [42] PRION PROTEIN TRANSGENES AND THE NEUROPATHOLOGY IN PRION-DISEASES
    DEARMOND, S
    PRUSINER, SB
    BRAIN PATHOLOGY, 1995, 5 (01) : 77 - 89
  • [43] Protection from cytosolic prion protein toxicity by modulation of protein translocation
    Rane, NS
    Yonkovich, JL
    Hegde, RS
    EMBO JOURNAL, 2004, 23 (23): : 4550 - 4559
  • [44] Prion proteins meet protein quality control
    Dimcheff, DE
    Portis, JL
    Caughey, B
    TRENDS IN CELL BIOLOGY, 2003, 13 (07) : 337 - 340
  • [45] Biochemical fingerprints of prion diseases: scrapie prion protein in human prion diseases that share prion genotype and type
    Pan, T
    Li, RL
    Kang, SC
    Pastore, M
    Wong, BS
    Ironside, J
    Gambetti, P
    Sy, MS
    JOURNAL OF NEUROCHEMISTRY, 2005, 92 (01) : 132 - 142
  • [46] The effects of prion protein expression on metal metabolism
    Kralovicova, Silvia
    Fontaine, Sarah N.
    Alderton, Alexandra
    Alderman, Julia
    Ragnarsdottir, K. Vala
    Collins, Steven J.
    Brown, David R.
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2009, 41 (02) : 135 - 147
  • [47] Prion protein aggregation
    Jain, Shweta
    Udgaonkar, Jayant B.
    CURRENT SCIENCE, 2011, 101 (10): : 1311 - 1327
  • [48] Prion: the chameleon protein
    Zou, W. Q.
    Gambetti, P.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2007, 64 (24) : 3266 - 3270
  • [49] Prion protein glycosylation
    Lawson, VA
    Collins, SJ
    Masters, CL
    Hill, AF
    JOURNAL OF NEUROCHEMISTRY, 2005, 93 (04) : 793 - 801
  • [50] Identification of candidate proteins binding to prion protein
    Yehiely, F
    Bamborough, P
    DaCosta, M
    Perry, BJ
    Thinakaran, G
    Cohen, FE
    Carlson, GA
    Prusiner, SB
    NEUROBIOLOGY OF DISEASE, 1997, 3 (04) : 339 - 355